0001209191-21-009357.txt : 20210210
0001209191-21-009357.hdr.sgml : 20210210
20210210175223
ACCESSION NUMBER: 0001209191-21-009357
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Countouriotis Athena
CENTRAL INDEX KEY: 0001571469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38871
FILM NUMBER: 21615422
MAIL ADDRESS:
STREET 1: C/O AMBIT BIOSCIENCES CORPORATION
STREET 2: 11080 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Turning Point Therapeutics, Inc.
CENTRAL INDEX KEY: 0001595893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463826166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-926-5251
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: TP Therapeutics, Inc.
DATE OF NAME CHANGE: 20181018
FORMER COMPANY:
FORMER CONFORMED NAME: TP Therapeutics, INC
DATE OF NAME CHANGE: 20140106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-08
0
0001595893
Turning Point Therapeutics, Inc.
TPTX
0001571469
Countouriotis Athena
C/O TURNING POINT THERAPEUTICS, INC.
10628 SCIENCE CENTER DRIVE, STE. 200
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Common Stock
2021-02-08
4
A
0
22617
0.00
A
50195
D
Stock Option (right to buy)
140.01
2021-02-08
4
A
0
101775
0.00
A
2031-02-07
Common Stock
101775
101775
D
Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
Includes 369 shares acquired by the Reporting Person on June 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan (the "ESPP") and 337 shares acquired on December 10, 2020 pursuant the ESPP.
1/48th of the shares vest monthly following February 8, 2021.
/s/ Annette North, Attorney-in-Fact
2021-02-10